| Authors: |
Merkel EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. emily.merkel@seattlechildrens.org.; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. emily.merkel@seattlechildrens.org., Meyer CL; NMDP, Minneapolis, MN, USA., Yusuf RA; NMDP, Minneapolis, MN, USA., Morrison CF; College of Nursing, University of Cincinnati, Cincinnati, OH, USA., Kelly DL; College of Nursing, University of Florida, Gainesville, FL, USA., Levine DR; Division of Quality-of-life and Palliative Care, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Ullrich CK; Harvard Medical School, Boston, MA, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA., El-Jawahri A; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA. |
